» Articles » PMID: 30542437

LncRNA HOTAIR Improves Diabetic Cardiomyopathy by Increasing Viability of Cardiomyocytes Through Activation of the PI3K/Akt Pathway

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2018 Dec 14
PMID 30542437
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The current study aimed to investigate the role of long non-coding RNA (lncRNA) homeobox transcript antisense RNA (HOTAIR) in the pathogenesis of diabetic cardiomyopathy. Patients with diabetic cardiomyopathy, patients with diabetes but without cardiomyopathy and healthy controls were included in the current study. All participants underwent myocardial biopsy to collect myocardial tissues. Blood samples were also collected from each participant to prepare serum. Expression of HOTAIR in myocardial tissues was detected by reverse transcription-quantitative polymerase chain reaction. Receiver operating characteristic curve analysis was performed to evaluate the diagnostic value of serum HOTAIR for diabetic cardiomyopathy. AC16 human cardiomyocyte cells were treated with high glucose to observe the changes in expression of HOTAIR and phosphorylation of Akt. HOTAIR expression vector was transfected into cells of AC16 cell line and the effects of HOTAIR overexpression on cell viability and Akt phosphorylation were detected by MTT assay and western blot analysis, respectively. HOTAIR expression was significantly downregulated in myocardial tissues and serum of patients with diabetic cardiomyopathy compared with patients with diabetes and healthy controls. Serum HOTAIR could be used to effectively distinguish patients with diabetic cardiomyopathy from healthy controls. High glucose treatment inhibited HOTAIR expression and Akt phosphorylation. HOTAIR overexpression promoted Akt phosphorylation. HOTAIR overexpression improved AC16 cell viability, while PI3K/Akt inhibitor treatment reduced this effect. LncRNA HOTAIR may improve diabetic cardiomyopathy by increasing the viability of cardiomyocytes through activation of the PI3K/Akt pathway.

Citing Articles

Long Non-Coding RNAs in Diabetic Cardiomyopathy: Potential Function as Biomarkers and Therapeutic Targets of Exercise Training.

Hu J, Miao X, Yu L J Cardiovasc Transl Res. 2025; .

PMID: 39786669 DOI: 10.1007/s12265-024-10586-8.


Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease.

Rai A, Muthukumaran N, Nisini N, Lee T, Kyriazis I, de Lucia C Cardiovasc Diabetol. 2024; 23(1):365.

PMID: 39420368 PMC: 11488282. DOI: 10.1186/s12933-024-02441-6.


lncRNA HOTAIR and Cardiovascular diseases.

Taghvimi S, Soltani Fard E, Khatami S, Zafaranchi Z M S, Taheri-Anganeh M, Movahedpour A Funct Integr Genomics. 2024; 24(5):165.

PMID: 39294422 DOI: 10.1007/s10142-024-01444-6.


Protective effects of carvacrol on lipid profiles, oxidative stress, hypertension, and cardiac dysfunction - A comprehensive review.

Khazdair M, Moshtagh M, Anaeigoudari A, Jafari S, Kazemi T Food Sci Nutr. 2024; 12(5):3137-3149.

PMID: 38726397 PMC: 11077248. DOI: 10.1002/fsn3.4014.


Circulating Levels of HOTAIR- lncRNA Are Associated with Disease Progression and Clinical Parameters in Type 2 Diabetes Patients.

Niknam N, Nikooei S, Ghasemi H, Zadian S, Goudarzi K, Ahmadi S Rep Biochem Mol Biol. 2024; 12(3):448-457.

PMID: 38618258 PMC: 11015925. DOI: 10.61186/rbmb.12.3.448.


References
1.
Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

2.
Leung A, Amaram V, Natarajan R . Linking diabetic vascular complications with LncRNAs. Vascul Pharmacol. 2018; 114:139-144. PMC: 6070440. DOI: 10.1016/j.vph.2018.01.007. View

3.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

4.
Mayfield R . Emerging roles for ncRNAs in alcohol use disorders. Alcohol. 2017; 60:31-39. PMC: 5504532. DOI: 10.1016/j.alcohol.2017.01.004. View

5.
Wang K, Long B, Zhou L, Liu F, Zhou Q, Liu C . CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun. 2014; 5:3596. DOI: 10.1038/ncomms4596. View